Asamura Hisao, Aokage Keiju, Yotsukura Masaya
From the Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan; Division of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan; Keio University School of Medicine, Tokyo, Japan.
Am Soc Clin Oncol Educ Book. 2017;37:426-433. doi: 10.1200/EDBK_179730.
Currently, surgery for lung cancer with curative intent consists of resection (removal) of the proper extent of lung parenchyma that bears the cancer lesion along with locoregional lymph nodes to assess possible cancer metastasis. Lobectomy, at least, is preferred with regard to the extent of parenchymal resection. The history of lung cancer surgery, which started around 1933 as pneumonectomy (resection of the entire lung on either side), can be characterized as an attempt to minimize the extent of parenchymal resection. In the early 1960s, pneumonectomy was replaced by lobectomy, which has long been respected as the standard surgical mode. However, the transition from lobectomy to a lesser resection, such as segmentectomy or wedge resection, was not recommended because of the results of a randomized trial performed by the North American Lung Cancer Study Group in the 1980s. As of now, the extent of parenchymal resection remains lobectomy, and lesser resection is indicated only for patients who have a compromised pulmonary reserve. Very recently, because of the advent of CT screening programs and improvements in imaging technology, fainter and smaller lung cancers are being discovered. For these smaller and earlier lung cancers, there is some uncertainty about whether lobectomy still should be indicated, as it is for larger tumors with a diameter of 3 cm or more. Therefore, several randomized trials are ongoing to compare lobectomy with lesser resections; endpoints are overall survival and postoperative pulmonary function. Until the results of these trials are available, lung cancer should still be removed by lobectomy rather than by limited resection, such as segmentectomy or wedge resection.
目前,旨在治愈肺癌的手术包括切除带有癌灶的适当范围的肺实质以及区域淋巴结,以评估可能的癌症转移情况。就实质切除范围而言,至少应首选肺叶切除术。肺癌手术的历史始于1933年左右的全肺切除术(切除一侧的整个肺),其特点是试图尽量减少实质切除范围。在20世纪60年代早期,全肺切除术被肺叶切除术所取代,肺叶切除术长期以来一直被视为标准的手术方式。然而,由于北美肺癌研究组在20世纪80年代进行的一项随机试验结果,不建议从肺叶切除术过渡到范围较小的切除术,如肺段切除术或楔形切除术。截至目前,实质切除范围仍为肺叶切除术,仅对于肺储备功能受损的患者才考虑范围较小的切除术。最近,由于CT筛查项目的出现和成像技术的改进,越来越多隐匿性更强、体积更小的肺癌被发现。对于这些更小、更早期的肺癌,对于是否仍应像治疗直径3厘米及以上的较大肿瘤那样采用肺叶切除术存在一些不确定性。因此,正在进行几项随机试验来比较肺叶切除术与范围较小的切除术;终点指标为总生存期和术后肺功能。在这些试验结果出来之前,肺癌仍应通过肺叶切除术而非有限切除,如肺段切除术或楔形切除术来切除。